These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 38305308
1. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J, Luo J, Gan R, Zhi L, Zhou H, Lv M, Huang Y, Liang G. Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308 [Abstract] [Full Text] [Related]
2. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M, Zhou LY, Xu N, An Q. Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884 [Abstract] [Full Text] [Related]
3. Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway. Gu F, Zhou Y, Tian L, Chen J, Zhang C, Huang Z, Yu W, Xie K. Sci Rep; 2024 Sep 10; 14(1):21130. PubMed ID: 39256509 [Abstract] [Full Text] [Related]
5. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J, Snijders AM, Wei G, Mao JH, Zhang P. Cell Oncol (Dordr); 2020 Jun 10; 43(3):395-407. PubMed ID: 32006253 [Abstract] [Full Text] [Related]
6. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT. Zhao YY, Jia J, Zhang JJ, Xun YP, Xie SJ, Liang JF, Guo HG, Zhu JZ, Ma SL, Zhang SR. Acta Pharmacol Sin; 2021 Aug 10; 42(8):1288-1297. PubMed ID: 33159174 [Abstract] [Full Text] [Related]
7. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. Wei N, Wu X, Yu Y, Zhou H, Cui K, Zhao X, Zhang X. Front Biosci (Landmark Ed); 2024 Apr 08; 29(4):140. PubMed ID: 38682195 [Abstract] [Full Text] [Related]
8. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, Ahn KS. Pharmacol Res; 2019 Dec 08; 150():104504. PubMed ID: 31678208 [Abstract] [Full Text] [Related]
9. Saponins isolated from Schizocapsa plantaginea inhibit human hepatocellular carcinoma cell growth in vivo and in vitro via mitogen-activated protein kinase signaling. Sun YW, Qiu HC, Ou MC, Chen RL, Liang G. Chin J Nat Med; 2018 Jan 08; 16(1):29-40. PubMed ID: 29425588 [Abstract] [Full Text] [Related]
10. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L, Zhang J, Fan Y, Li Y. Med Sci Monit; 2019 Oct 21; 25():7864-7871. PubMed ID: 31631173 [Abstract] [Full Text] [Related]
12. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells. Luo W, Liu Q, Jiang N, Li M, Shi L. Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31467176 [Abstract] [Full Text] [Related]
13. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam D, Lee J, Lee SG, Yang WM, Um JY, Sethi G, Ahn KS. J Cell Physiol; 2017 Feb 30; 232(2):346-354. PubMed ID: 27177359 [Abstract] [Full Text] [Related]
14. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway. Chen M, Hu C, Guo Y, Jiang R, Jiang H, Zhou Y, Fu H, Wu M, Zhang X. Oncol Rep; 2018 Sep 30; 40(3):1339-1347. PubMed ID: 29956803 [Abstract] [Full Text] [Related]
15. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Wang N, Feng T, Liu X, Liu Q. Acta Pharm; 2020 Sep 01; 70(3):399-409. PubMed ID: 32074070 [Abstract] [Full Text] [Related]
16. Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway. Chen XF, Liu PG, Sheng N, Li XS, Hu RK, Zhu LX, Feng P. PLoS One; 2024 Sep 01; 19(9):e0308947. PubMed ID: 39331595 [Abstract] [Full Text] [Related]
17. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y, Song T, Shi Z, Li W, Yang S, Li D. Gene; 2021 Feb 05; 768():145309. PubMed ID: 33197518 [Abstract] [Full Text] [Related]
18. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells. Jung YY, Baek SH, Narula AS, Namjoshi OA, Blough BE, Ahn KS. Life Sci; 2021 Nov 01; 284():119893. PubMed ID: 34454947 [Abstract] [Full Text] [Related]
19. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A, Li H, Li R, Lu L, Wu X. Oncol Rep; 2018 Oct 01; 40(4):2353-2362. PubMed ID: 30066933 [Abstract] [Full Text] [Related]
20. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway. Zhang K, Lin G, Nie Z, Jin S, Bing X, Li Z, Li M. Mol Cell Biochem; 2024 Aug 01; 479(8):2069-2079. PubMed ID: 37566200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]